Active involvement, enthusiasm mark CTTI’s first year
Fifty-one organizations joined CTTI in 2008. Each is represented on the CTTI Steering Committee. An Executive Committee was also established to provide overall direction and leadership.
Date: January 13, 2009
Great stakeholder enthusiasm, a strong organizational foundation, and rapid progress in a number of projects defined CTTI’s first year.
Fifty-one organizations joined CTTI in 2008. These organizations represent industry (pharmaceutical, biotech, device, and clinical research organizations), the FDA and other government agencies, investigators, academia, and other stakeholders with expertise and interest in making improvements to the clinical research enterprise.
Each member organization is represented on the CTTI Steering Committee. An Executive Committee representing a broad range of relevant expertise was also established to provide overall direction and leadership to CTTI.
The active involvement of its leaders, members, and government partners helped CTTI launch two cornerstone projects.
One of CTTI’s first projects, "Effective and Efficient Monitoring as a Component of Quality Assurance in the Conduct of Clinical Trials" is designed to assess a variety of clinical monitoring approaches to provide information that will assist medical products researchers in selecting the most appropriate monitoring methods for clinical trials.
The second project, "Interpreting and Communicating Clinical Data in the Public Domain," aims to bring together stakeholders who are engaged in the collection, reporting, and interpretation of clinical data in the public domain to develop consensus on principles to analyze and report such data.
CTTI is also developing project plans for two additional approved project concepts.
Read more about CTTI’s accomplishments in detail here.